Task: Answer the following question about the molecule with SMILES CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+].
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Approved
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+]
CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+]
sodium;butylcarbamoyl-(4-methylphenyl)sulfonylazanide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.